|
| |||||||||||
AccBio 2027 : 10th International Conference on Accelerating Biopharmaceutical Development (AccBio 2027) | |||||||||||
| Link: https://www.aiche.org/sbe/conferences/accelerating-biopharmaceutical-development/2027?utm_source=WikiCFP&utm_medium=Web&utm_campaign=AccBio2027 | |||||||||||
| |||||||||||
Call For Papers | |||||||||||
|
How can we accelerate biopharmaceutical development at every stage? From early development and analytics to manufacturing, scale-up, and delivery, the industry is rethinking how to move biotherapeutics forward faster.
The International Conference on Accelerating Biopharmaceutical Development (AccBio 2027) brings together leading pharmaceutical companies, industry decision-makers, technical experts, and innovators to discuss what's next for biopharmaceutical development — and how to get there faster. This is more than a conversation about scientific advances. It's about the strategies, technologies, processes, and decisions needed to accelerate the entire development lifecycle. We invite you to submit an abstract and contribute your expertise, experiences, and perspectives to these important industry conversations. SESSION TOPICS: Accelerating Development While Managing Risk: Explores the balance between accelerating biopharmaceutical development and managing clinical, CMC, and regulatory risks. Discussions will examine industry challenges, evolving regulations, legacy processes, and global competition, highlighting both successful acceleration strategies and lessons learned. End-to-End Bioprocess Acceleration: Focuses on how AI, machine learning, predictive modeling, and digital technologies can speed up decision-making across drug discovery, process development, and manufacturing. Also addresses data limitations, organizational readiness, and the cultural changes needed to successfully adopt digital tools. Digital, Data & Predictive Technologies: Examines opportunities to accelerate development across the entire biopharmaceutical pipeline, from analytical development and drug substance to manufacturing, drug product, and delivery. Highlights cross-functional collaboration, developability, combination products, global innovation hubs, and post-acquisition R&D challenges. Learn more and submit your abstract: https://www.aiche.org/sbe/conferences/accelerating-biopharmaceutical-development/2027?utm_source=WikiCFP&utm_medium=Web&utm_campaign=AccBio2027 Conference Chairs Jennifer Pollard, Bristol Myers Squibb Nihal Tugcu, Sanofi Organizing Committee Dana Andersen, Denali Therapeutics Glen Bolton, Amgen Rubi Burlage, Merck Charles Cooney, MIT Brandon Downey, Lonza Greg Naugle, GSK Arup Roy, Eli Lily Jeff Salm, Pfizer Jeremy Shaver, Pfizer Raghu Shivappa, Takeda Trevor Swartz, Genentech Andrew Tustian, Regeneron About SBE Established in 2004, the Society for Biological Engineering is a technological community for engineers and applied scientists integrating biology with engineering. Members of SBE come from a broad spectrum of industries and disciplines and share in SBE’s mission of realizing the benefits of bioprocessing, biomedical and biomolecular applications. Learn more about SBE at https://www.aiche.org/sbe |
|